Bill

Bill > S801


US S801

A bill to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information.


summary

Introduced
03/14/2019
In Committee
03/14/2019
Crossed Over
Passed
Dead
12/31/2020

Introduced Session

116th Congress

Bill Summary

A bill to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. This bill allows certain payment information relating to covered drugs under the Medicare prescription drug benefit and Medicaid to be disclosed to additional entities. Specifically, certain subsidy and rebate information, as reported by prescription drug plan sponsors and drug manufacturers, may be disclosed to the Medicare Payment Advisory Commission and the Medicaid and Children's Health Insurance Program (CHIP) Payment and Access Commission, in accordance with specified confidentiality restrictions.

AI Summary

This bill allows the Medicare Payment Advisory Commission (MedPAC) and the Medicaid and CHIP Payment and Access Commission (MACPAC) to access certain drug payment and rebate information from the Medicare prescription drug benefit and Medicaid programs. Specifically, it permits the Executive Directors of these commissions to review drug subsidy and rebate data reported by prescription drug plan sponsors and drug manufacturers, subject to confidentiality restrictions. This is intended to help these commissions monitor, make recommendations, and analyze these government healthcare programs.

Committee Categories

Budget and Finance

Sponsors (4)

Last Action

Read twice and referred to the Committee on Finance. (on 03/14/2019)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...